vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
26.45
-1.14 (-4.15%)
At close: Oct 16, 2026, 4:00 PM EDT
26.54
+0.09 (0.36%)
After-hours: Oct 16, 2026, 7:30 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $329.75 million as of October 16, 2026. It is the 17,603rd most valuable company in the world and the 3,086th biggest in the United States. Its market cap has increased by 86.06% in one year.
Market Cap
329.75M
Enterprise Value
243.11M
1-Year Change
86.06%
Global Rank
Country Rank
#3,086 United States
Category
ChartMarket Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $329.75M, an increase of 322.09%. That is a compound annual growth rate of 13.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 329.75M | -33.55% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 363.33M |
| Fennec Pharmaceuticals | 362.95M |
| Turn Therapeutics | 345.24M |
| Orchestra BioMed Holdings | 345.00M |
| C4 Therapeutics | 342.01M |
| Prelude Therapeutics | 341.94M |
| Relmada Therapeutics | 341.34M |
| Opus Genetics | 336.94M |